CRDF EBITDA Growth
Cardiff Oncology Inc · EBITDA Growth
CRDF EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported22.78%period ending
CRDF TTM EBITDA YoY % (-6.26% → 22.78%)
Year-over-year change
High-resolution chart · PNG
CRDF ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 22.7817% | |
| 9.786% | |
| 0.7773% | |
| -15.9854% | |
| -24.5425% | |
| -21.3592% | |
| -9.7069% | |
| -5.3191% | |
| -2.9374% | |
| -3.0539% | |
| -6.6939% | |
| -4.4283% | |
| -6.1239% | |
| -16.1656% | |
| -39.2608% | |
| -52.5483% | |
| -62.2363% | |
| -65.0151% | |
| -46.6271% | |
| -113.6663% | |
| -94.848% | |
| -70.5121% | |
| -61.6882% | |
| 25.8605% | |
| 24.3733% | |
| 20.6774% | |
| 25.3077% | |
| -9.8011% | |
| -3.2279% | |
| 14.2173% | |
| 25.4217% | |
| 43.2209% | |
| 52.3% | |
| 50.6548% | |
| 44.1239% | |
| 30.4242% | |
| 6.1741% | |
| -15.7453% | |
| -50.3672% | |
| -67.2567% | |
| -61.9772% | |
| -101.3157% | |
| -83.9132% | |
| -85.4976% | |
| -82.6664% | |
| 3.1867% | |
| -0.3167% | |
| 46.6771% | |
| 40.3578% | |
| -4.0753% | |
| 10.3965% | |
| -418.6818% | |
| -374.0995% | |
| -340.3284% | |
| -407.6365% | |
| -33.1498% | |
| 37.4257% | |
| 44.2392% | |
| 46.1612% | |
| 46.2552% | |
| -67.4161% | |
| -76.2095% | |
| 62.7718% | |
| 31.5825% | |
| -6.2592% |